In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A

doi:10.1084/jem.177.2.551

This Article

	Full Text (PDF, 535K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Durez, P.
	Articles by Goldman, M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Durez, P.
	Articles by Goldman, M.


Social Bookmarking

	What's this?

ARTICLES

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A

P Durez, D Abramowicz, C Gerard, M Van Mechelen, Z Amraoui, C Dubois, O Leo, T Velu and M Goldman
Laboratoire Pluridisciplinaire de Recherche Experimentale Biomedicale, Hopital Erasme, Brussels, Belgium.

We investigated the in vivo effects of cyclosporin A (CsA) on the production of interleukin (IL) 10, a cytokine with major immunosuppressive properties. To elicit IL-10 production in vivo, BALB/c mice were injected either with the anti-mouse CD3 145-2C11 monoclonal antibody (mAb) (25 micrograms) or with bacterial lipopolysaccharide (LPS) (20 micrograms). A systemic release of IL-10 was observed in both models, IL-10 serum levels reaching 1.60 +/- 0.32 U/ml (mean +/- SEM) and 0.67 +/- 0.09 U/ml 6 h after injection of 145- 2C11 mAb and LPS, respectively. Experiments in nude mice indicated that T cells are involved in the induction of IL-10 by anti-CD3 mAb, but not by LPS. Pretreatment with CsA (total dose: 50 mg/kg) before injection of 145-2C11 mAb completely prevented the release of IL-10 in serum as well as IL-10 mRNA accumulation in spleen cells. In contrast, CsA markedly enhanced LPS-induced IL-10 release (IL-10 serum levels at 6 h: 8.31 +/- 0.43 vs. 0.71 +/- 0.15 U/ml in mice pretreated with CsA vehicle-control, p < 0.001), as well as IL-10 mRNA accumulation in spleen. We conclude that CsA differentially affects IL-10 production in vivo depending on the nature of the eliciting agent. This observation might be relevant to clinical settings, especially in organ transplantation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Bharhani, M. S., Borojevic, R., Basak, S., Ho, E., Zhou, P., Croitoru, K. (2006). IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G820-G829 [Abstract] [Full Text]
Yoo, S.-A., Park, B.-H., Park, G.-S., Koh, H.-S., Lee, M.-S., Ryu, S. H., Miyazawa, K., Park, S.-H., Cho, C.-S., Kim, W.-U. (2006). Calcineurin Is Expressed and Plays a Critical Role in Inflammatory Arthritis. J. Immunol. 177: 2681-2690 [Abstract] [Full Text]
Zhou, P., Streutker, C., Borojevic, R., Wang, Y., Croitoru, K. (2004). IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G599-G604 [Abstract] [Full Text]
von Herrath, M. G., Coon, B., Wolfe, T., Chatenoud, L. (2002). Nonmitogenic CD3 Antibody Reverses Virally Induced (Rat Insulin Promoter-Lymphocytic Choriomeningitis Virus) Autoimmune Diabetes Without Impeding Viral Clearance. J. Immunol. 168: 933-941 [Abstract] [Full Text]
Kelly, A., Lynch, A., Vereker, E., Nolan, Y., Queenan, P., Whittaker, E., O'Neill, L. A. J., Lynch, M. A. (2001). The Anti-inflammatory Cytokine, Interleukin (IL)-10, Blocks the Inhibitory Effect of IL-1beta on Long Term Potentiation. A ROLE FOR JNK. J. Biol. Chem. 276: 45564-45572 [Abstract] [Full Text]
Van Wauwe, J., Aerts, F., Cools, M., Deroose, F., Freyne, E., Goossens, J., Hermans, B., Lacrampe, J., Van Genechten, H., Van Gerven, F., Van Nyen, G. (2000). Identification of R146225 as a Novel, Orally Active Inhibitor of Interleukin-5 Biosynthesis. J. Pharmacol. Exp. Ther. 295: 655-661 [Abstract] [Full Text]
Senaldi, G., Shaklee, C. L., Guo, J., Martin, L., Boone, T., W. Mak, T., Ulich, T. R. (1999). Protection Against the Mortality Associated with Disease Models Mediated by TNF and IFN-{gamma} in Mice Lacking IFN Regulatory Factor-1. J. Immunol. 163: 6820-6826 [Abstract] [Full Text]
Conboy, I. M., Manoli, D., Mhaiskar, V., Jones, P. P. (1999). Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions. Proc. Natl. Acad. Sci. USA 96: 6324-6329 [Abstract] [Full Text]
Leon, L. R., Kozak, W., Rudolph, K., Kluger, M. J. (1999). An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 276: R81-R89 [Abstract] [Full Text]
Sacco, S., Heremans, H., Echtenacher, B., Buurman, W. A., Amraoui, Z., Goldman, M., Ghezzi, P. (1997). Protective Effect of a Single Interleukin-12 (IL-12) Predose Against the Toxicity of Subsequent Chronic IL-12 in Mice: Role of Cytokines and Glucocorticoids. Blood 90: 4473-4479 [Abstract] [Full Text]
Wan, S., Marchant, A., DeSmet, J.-M., Antoine, M., Zhang, H., Vachiery, J.-L., Goldman, M., Vincent, J.-L., LeClerc, J.-L. (1996). HUMAN CYTOKINE RESPONSES TO CARDIAC TRANSPLANTATION AND CORONARY ARTERY BYPASS GRAFTING. J. Thorac. Cardiovasc. Surg. 111: 469-477 [Abstract] [Full Text]